Cipla informs about press release

02 Apr 2020 Evaluate

Cipla has informed that the company has enclosed a press release dated 2nd April 2020 regarding ‘Cipla announces successful completion of Phase-3 clinical study for generic version of GSK’s Advair Diskus’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1400.00 52.30 (3.88%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.